EP2981271 - THERAPEUTIC USES OF EMPAGLIFLOZIN [Right-click to bookmark this link] | Status | Opposition rejected Status updated on 20.03.2024 Database last updated on 03.04.2025 | |
Former | The patent has been granted Status updated on 12.10.2018 | ||
Former | Grant of patent is intended Status updated on 30.05.2018 | ||
Former | Examination is in progress Status updated on 29.09.2017 | ||
Former | Request for examination was made Status updated on 01.09.2017 | ||
Former | Grant of patent is intended Status updated on 05.04.2017 | Most recent event Tooltip | 03.10.2024 | Change - lapse in a contracting state State(s) deleted from list of lapses: AL | published on 06.11.2024 [2024/45] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2018/46] |
Former [2016/06] | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Inventor(s) | 01 /
BROEDL, Uli Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | 02 /
VON EYNATTEN, Maximilian Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | 03 /
MACHA, Sreeraj Boehringer Ingelheim USA Corp. c/o VP IP Legal, 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | 04 /
WOERLE, Hans-Juergen Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2016/06] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
Former [2016/06] | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 14715578.2 | 03.04.2014 | [2016/06] | WO2014EP56657 | Priority number, date | US201361808804P | 05.04.2013 Original published format: US 201361808804 P | CA20132812519 | 10.04.2013 Original published format: CA 2812519 | US201361908991P | 26.11.2013 Original published format: US 201361908991 P | [2016/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014161919 | Date: | 09.10.2014 | Language: | EN | [2014/41] | Type: | A1 Application with search report | No.: | EP2981271 | Date: | 10.02.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.10.2014 takes the place of the publication of the European patent application. | [2016/06] | Type: | B1 Patent specification | No.: | EP2981271 | Date: | 14.11.2018 | Language: | EN | [2018/46] | Search report(s) | International search report - published on: | EP | 09.10.2014 | Classification | IPC: | A61K31/7048, A61P3/10, A61P13/12 | [2016/06] | CPC: |
A61K31/7048 (EP,KR,MX,US);
A61K31/7034 (US);
A61K9/2018 (US);
A61K9/2866 (US);
A61P13/00 (EP);
A61P13/12 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/06] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | THERAPEUTISCHE VERWENDUNGEN VON EMPAGLIFLOZIN | [2016/06] | English: | THERAPEUTIC USES OF EMPAGLIFLOZIN | [2016/06] | French: | USAGES THÉRAPEUTIQUES D'EMPAGLIFLOZINE | [2016/06] | Entry into regional phase | 05.11.2015 | National basic fee paid | 05.11.2015 | Designation fee(s) paid | 05.11.2015 | Examination fee paid | Examination procedure | 30.10.2015 | Amendment by applicant (claims and/or description) | 05.11.2015 | Examination requested [2016/06] | 06.04.2017 | Communication of intention to grant the patent | 19.07.2017 | Observations by third parties | 02.08.2017 | Observations by third parties | 14.08.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.08.2017 | Fee for grant paid | 16.08.2017 | Fee for publishing/printing paid | 28.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2018 | Reply to a communication from the examining division | 31.05.2018 | Communication of intention to grant the patent | 01.10.2018 | Receipt of the translation of the claim(s) | 11.09.2019 | Observations by third parties | Divisional application(s) | EP18197967.5 / EP3456332 | Opposition(s) | Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | 02
09.08.2019
21.10.2019
WITHDRAWN Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | 03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | 04
14.08.2019
21.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Kraus & Lederer PartGmbB, et al, et al Thomas-Wimmer-Ring 15 80539 München / DE | 05
14.08.2019
21.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | 06
14.08.2019
21.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | 07
14.08.2019
21.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | 08
14.08.2019
21.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [N/P] |
Former [2024/04] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | ||
02
09.08.2019
21.10.2019
WITHDRAWN Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | |||
04
14.08.2019
21.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Kraus & Weisert Patentanwälte PartGmbB, et al, et al Thomas-Wimmer-Ring 15 80539 München / DE | |||
05
14.08.2019
21.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | |||
06
14.08.2019
21.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | |||
07
14.08.2019
21.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
08
14.08.2019
21.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2021/47] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | ||
02
09.08.2019
21.10.2019
WITHDRAWN Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | |||
04
14.08.2019
21.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Lederer & Keller Patentanwälte Partnerschaft mbB, et al, et al Unsöldstraße 2 80538 München / DE | |||
05
14.08.2019
21.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | |||
06
14.08.2019
21.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | |||
07
14.08.2019
21.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
08
14.08.2019
21.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2021/02] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | ||
02
09.08.2019
21.10.2019
WITHDRAWN Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | |||
04
14.08.2019
21.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street 49131 Petach-Tikva / IL Opponent's representative Lederer & Keller Patentanwälte Partnerschaft mbB, et al, et al Unsöldstraße 2 80538 München / DE | |||
05
14.08.2019
21.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | |||
06
14.08.2019
21.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | |||
07
14.08.2019
21.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
08
14.08.2019
21.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2019/48] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | ||
02
09.08.2019
21.10.2019
WITHDRAWN Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | |||
04
14.08.2019
21.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street 49131 Petach-Tikva / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | |||
05
14.08.2019
21.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | |||
06
14.08.2019
21.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | |||
07
14.08.2019
21.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
08
14.08.2019
21.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2019/38] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | ||
02
09.08.2019
15.08.2019
ADMISSIBLE Alfred E. Tiefenbacher (GmbH & Co. KG) Van-der-Smissen-Straße 1 22767 Hamburg / DE Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
03
12.08.2019
15.08.2019
ADMISSIBLE EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Keresztúri út 30-38 1106 Budapest / HU Opponent's representative Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | |||
04
14.08.2019
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street 49131 Petach-Tikva / IL Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | |||
05
14.08.2019
ADMISSIBLE Stada-Arzneimittel Aktiengesellschaft Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Kernebeck, Thomas Kernebeck Patentanwalts GmbH Stiftstraße 2 60313 Frankfurt am Main / DE | |||
06
14.08.2019
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Herts AL 10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | |||
07
14.08.2019
ADMISSIBLE ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. ul. Pelplinska 19 83-200 Starogard Gdanski / PL Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
08
14.08.2019
ADMISSIBLE Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2019/37] | |||
Opponent(s) | 01
02.08.2019
07.08.2019
ADMISSIBLE KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo Mesto / SI Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | 30.08.2019 | Invitation to proprietor to file observations on the notice of opposition | 09.03.2020 | Reply of patent proprietor to notice(s) of opposition | 18.12.2020 | Cancellation of oral proceeding that was planned for 12.01.2021 | 12.01.2021 | Date of oral proceedings | 18.05.2021 | Date of oral proceedings | 25.06.2021 | Despatch of minutes of oral proceedings | 25.06.2021 | Despatch of communication that the patent will be revoked | 09.02.2024 | Legal effect of rejection of opposition [2024/17] | 20.03.2024 | Date of despatch of rejection of opposition | Appeal following opposition | 01.09.2021 | Appeal received No. T1437/21 | 01.09.2021 | Payment of appeal fee | 05.11.2021 | Statement of grounds filed | 09.02.2024 | Result of appeal procedure: maintenance in unamended form | 20.03.2024 | Despatch of the decision of the Board of Appeal | 09.02.2024 | Date of oral proceedings | Fees paid | Renewal fee | 02.05.2016 | Renewal fee patent year 03 | 02.05.2017 | Renewal fee patent year 04 | 30.04.2018 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 14.11.2018 | [2024/45] |
Former [2019/37] | AL | 14.11.2018 | |
SM | 14.11.2018 | ||
Former [2019/26] | AL | 14.11.2018 | Cited in | International search | [A]WO2011039337 (BOEHRINGER INGELHEIM INT [DE], et al); | [A]WO2013007557 (BOEHRINGER INGELHEIM INT [DE], et al); | Opposition | WO2006117359 | WO2009022007 | WO2014161919 | WO2011039337 | WO2013007557 | CA2812519 | EP2981271 |